Discover
APYX
Apyx Medical Corporation
4.34
1 x 3.50
2 x 5.63
bid
ask
-
0.32
6.87%
02:00 PM
timesize
| Ytd | 24.00% | |
| 1y | 101.86% |
4.32
day range
4.80
1.59
52 week range
5.08
| Open | 4.70 | Prev Close | 4.66 | Low | 4.32 | High | 4.80 | Mkt Cap | 182.76M |
| Vol | 34.37K | Avg Vol | 181.76K | EPS | -0.22 | P/E | N/A | Forward P/E | -3.39 |
| Beta | 1.21 | Short Ratio | 5.49 | Inst. Own | 40.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.01 | 200-d Avg | 3.64 | 1yr Est | 2.83 |
| Income Statement | |||
| Total Revenue | 12.49M | ||
| Revenues (USD) | 12.49M | ||
| Cost of Revenue | 4.57M | ||
| Gross Profit | 7.93M | ||
| Operating Expenses | 8.84M | ||
| Research and Development Expense | 765.00K | ||
| Selling, General and Administrative Expense | 8.07M | ||
| Operating Income | -911.00K | ||
| Interest Expense | 1.37M | ||
| Income Tax Expense | 143.00K | ||
| Net Income | -2.11M | ||
| Net Income Common Stock | -2.11M | ||
| Net Income Common Stock (USD) | -2.11M | ||
| Consolidated Income | -2.14M | ||
| Net Income to Non-Controlling Interests | -35.00K | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -596.00K | ||
| Earning Before Interest & Taxes (USD) | -596.00K | ||
| Weighted Average Shares | 41.83M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.14M | ||
| Cash and Equivalents (USD) | 31.14M | ||
| Trade and Non-Trade Receivables | 12.76M | ||
| Current Assets | 54.80M | ||
| Property, Plant & Equipment Net | 6.35M | ||
| Total Assets | 63.03M | ||
| Debt Current | 441.00K | ||
| Total Debt | 39.46M | ||
| Current Liabilities | 9.45M | ||
| Debt Non-Current | 39.02M | ||
| Total Liabilities | 49.94M | ||
| Accumulated Retained Earnings (Deficit) | -91.23M | ||
| Shareholders Equity | 12.83M | ||
| Shareholders Equity (USD) | 12.83M | ||
| Assets Non-Current | 8.23M | ||
| Total Debt (USD) | 39.46M | ||
| Deferred Revenue | 1.13M | ||
| Inventory | 9.54M | ||
| Liabilities Non-Current | 40.49M | ||
| Trade and Non-Trade Payables | 2.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 222.00K | ||
| Net Cash Flow from Financing | 83.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -603.00K | ||
| Capital Expenditure | -60.00K | ||
| Issuance (Purchase) of Equity Shares | 88.00K | ||
| Issuance (Repayment) of Debt Securities | -5.00K | ||
| Net Cash Flow from Investing | -60.00K | ||
| Net Cash Flow from Operations | -572.00K | ||
| Effect of Exchange Rate Changes on Cash | -54.00K | ||
| Share Based Compensation | 312.00K | ||